AstraZeneca PLC (AZN) vs The Charles Schwab Corporation (SCHW)
AZN leads on 8 of 14 compared metrics, though SCHW is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and The Charles Schwab Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
AZN
AstraZeneca PLC
$178.75Healthcare
SCHW
The Charles Schwab Corporation
$91.10Financial Services
Total return — AZN vs SCHW
growth of $100 · last 30yAZN +732.9%SCHW +2395.9%SCHW compounded faster
AZN SCHW
AZN vs SCHW: by the numbers
- •AZN is the larger company ($277.22B vs $158.44B market cap).
- •SCHW trades at the lower earnings multiple (18.08 vs 26.92 P/E).
- •SCHW converts more revenue to profit (33.26% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 14.85% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.30%).
Which is better, AZN or SCHW?
Metric tally: AZN 8 · SCHW 6It depends on what you're optimizing for:
ValueSCHW(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | SCHW |
|---|---|---|
| P/E ratio | 26.92 | 18.08● |
| Forward P/E | 15.33 | 12.44● |
| P/S ratio | 4.62● | 5.63 |
| P/B ratio | 5.90 | 3.24● |
| PEG ratio | 0.14● | 0.36 |
| EV / EBITDA | 14.92 | — |
| FCF yield | 2.89% | — |
Profitability
| Metric | AZN | SCHW |
|---|---|---|
| Gross margin | 81.68% | 87.57%● |
| Operating margin | 23.69% | 43.04%● |
| Net margin | 17.19% | 33.26%● |
| ROE | 21.95%● | 19.14% |
| ROIC | 13.03%● | 9.50% |
Dividends
| Metric | AZN | SCHW |
|---|---|---|
| Dividend yield | 1.79%● | 1.30% |
| Payout ratio | 48.48% | 25.21% |
Growth (annualized)
| Metric | AZN | SCHW |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 14.85% |
| EPS CAGR (5Y) | 22.02%● | 17.05% |
| FCF CAGR (5Y) | 15.68% | — |
| Total return CAGR (5Y) | 11.03%● | 5.66% |
Frequently asked
- Which is better, AZN or SCHW?
- It depends on your goal. value: SCHW (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 8 to 6.
- Is AZN or SCHW cheaper?
- On trailing earnings, SCHW is cheaper: AZN trades at a 26.92 P/E and SCHW at 18.08.
- Which has grown faster, AZN or SCHW?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus SCHW at 14.85%.
- Does AZN or SCHW pay a bigger dividend?
- AZN yields 1.79% and SCHW yields 1.30% based on trailing dividends and the latest price.
- Is AZN or SCHW more profitable?
- SCHW runs the higher net margin — AZN at 17.19% versus SCHW at 33.26%.
- Which has been the better investment, AZN or SCHW?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus SCHW at 13.78%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioCharles Schwab P/E ratioAstraZeneca dividend yieldCharles Schwab dividend yieldAstraZeneca ROECharles Schwab ROEAstraZeneca operating marginCharles Schwab operating marginAstraZeneca revenue growthCharles Schwab revenue growthAstraZeneca free cash flowCharles Schwab free cash flow
AstraZeneca & Charles Schwab appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.